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Coronaviruses encode an endoribonuclease, Nsp15, which has a poorly defined role in infection. Sequence analysis revealed a
retinoblastoma protein-binding motif (LXCXE/D) in the majority of the Nsp15 of the severe acute respiratory syndrome corona-
virus (SARS-CoV) and its orthologs in the alpha and beta coronaviruses. The endoribonuclease activity of the SARS-CoVNsp15
(sNsp15) was stimulated by retinoblastoma protein (pRb) in vitro, and the two proteins can be coimmunoprecipitated from cel-
lular extracts. Mutations in the pRb-binding motif rendered sNsp15 to be differentially modified by ubiquitin in cells, and cyto-
toxicity was observed upon its expression. Expression of the sNsp15 in cells resulted in an increased abundance of pRb in the
cytoplasm, decreased overall levels of pRb, an increased proportion of cells in the S phase of the cell cycle, and an enhanced ex-
pression from a promoter normally repressed by pRb. The endoribonuclease activity of the mouse hepatitis virus (MHV) A59
Nsp15 was also increased by pRb in vitro, and anMHVwith mutations in the LXCXE/D-motif, named vLC, exhibited a smaller
plaque diameter and reduced the virus titer by1 log. Overexpression of pRb delayed the viral protein production by wild-type
MHV but not by vLC. This study reveals that pRb and its interaction with Nsp15 can affect coronavirus infection and adds coro-
naviruses to a small but growing family of RNA viruses that encode a protein to interact with pRb.
Coronaviruses can cause diseases in humans, including severeacute respiratory syndrome (SARS), which had an associated
fatality rate of 10% during the 2002–2003 outbreak (17, 37).
Coronaviruses are also of interest for their30-kb positive-strand
genomes and novel mechanisms to express and process this large
RNA (12, 22, 25). All known members of nidovirus family that
includes coronaviruses encode an endoribonuclease, with the ex-
ception of Nam Dinh virus (33). A recombinant endoribonuclease
of the SARS-CoV (Nsp15) cleaves RNAs immediately 3= of uridy-
lates. This activity is stimulated by Mn2 but not by other divalent
metals, such as Mg2 (2). Furthermore, cleavage occurs through
the formation of a 2=-3= cyclic phosphodiester product in a mech-
anism identical to that of RNase A (4). Crystal structures of the
SARS-CoV and the mouse hepatitis virus (MHV) Nsp15 have
been reported, and both proteins form hexamers in solution (3,
36, 42).
Mutations in the active site of Nsp15 that apparently abolish
endoribonuclease activity in vitro reduce viral infectivity by up to
2 logs (20, 35). However, some mutations outside of the active site
are reported to have a larger effect on virus viability, suggesting
that Nsp15 has role(s) in coronavirus infection apart from its
function as an endoribonuclease (18, 20). In addition, the SARS-
CoV Nsp15 was identified in a screen for viral proteins that can
suppress apoptosis demonstrating that SARS-CoV Nsp15 can af-
fect host cell processes (24).
In order to better understand the role of SARS-CoV Nsp15 in
viral infection, we searched for motifs within sNsp15 and identi-
fied a sequence diagnostic for proteins that can bind the retino-
blastoma protein (pRb). This motif was originally identified in
oncoproteins encoded by DNA tumor viruses that can sequester
pRb and prevent the repression of genes needed for DNA replica-
tion (5, 10, 11, 41). Some RNA viruses are also known to interact
with pRb. Hepatitis C virus (HCV) can downregulate pRb and
enhance cell cycle progression (27). Intriguingly, the HCV RNA-
dependent RNA polymerase NS5B binds pRb and targets it for
ubiquitination and proteasomal degradation (27, 28). The mea-
sles virus also has a similar mechanism (30). The rubella virus
protein Nsp90 has also been shown to interact with pRb (1) and
affect virus replication (13). Although RNA viruses do not require
the host DNA replication machinery, their interaction with pRb
could result in alteration of the metabolic state of the cell and
affect virus infection (31, 34, 38).
In the present study, we examined the functional relevance of
the identified pRb-binding (LXCXE/D) motif on Nsp15 and stud-
ied the effects of Nsp15 on pRb and its functions. Further, we
examined the significance of pRb and its interaction with Nsp15
for MHV infection in cultured cells.
MATERIALS AND METHODS
Cells and viruses. DBT cells derived from a mouse brain tumor were
maintained at 37°C with 5% CO2 in Dulbecco modified Eagle medium
(DMEM) supplemented with 10% bovine calf serum (HyClone, Logan,
UT; catalog no. SH30072.03). Baby hamster kidney-21 cells expressing the
MHV receptor (BHK-R) were grown in minimal essential medium sup-
plemented with 10% bovine calf serum, 10% tryptose phosphate broth,
and G418 (800g/ml). Murine fibroblast cells (L2) were grown in DMEM
supplemented with 10% bovine calf serum and maintained at 37°C under
3% CO2. NIH 3T3 cells were grown at 37°C under 5% CO2 in DMEM with
4 mM L-glutamine, 1.5 g sodium bicarbonate/liter, and 4.5 g of glucose
(American Type Culture Collection; catalog no. 30-2002)/liter, and 10%
calf serum. MHV A59 and mutant derivatives were propagated in the DBT
cell line. 293T and Huh-7 cells were maintained at 37°C and 5% CO2 in
10% bovine calf serum containing, respectively, high-glucose DMEM
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with GlutaMAX (Invitrogen, Inc.; catalog no. 10569) and low-glucose
DMEM (Invitrogen, Inc.; catalog no.11885).
Protein purification. Wild-type (WT) and mutant Nsp15 proteins
containing a His6 tag at their respective N termini were expressed in Esch-
erichia coli Rosetta(DE3) pLys strain and purified by using metal ion af-
finity chromatography, followed by a Mono-Q and a gel filtration col-
umn, as described previously (2). The purified proteins were stored in 50
mM Tris (pH 7.9)–300 mM NaCl–1 mM dithiothreitol (DTT)–50% (vol/
vol) glycerol at20°C. The pRbAB (spanning AB domains of pRb; amino
acids 380 to 787) was expressed as a glutathione S-transferase (GST) fu-
sion in E. coli BL21(DE3) cells. Induction was carried out at 22°C for 16 h.
The protein was purified from cell lysate generated by sonication in 1
phosphate-buffered saline (PBS) containing 10 mM -mercaptoethanol.
The lysate was passed through a glutathione-Sepharose 4 Fast Flow (GE
Healthcare) affinity column, and protein was eluted with restriction-
grade thrombin (Novagen). Eluted fractions were further passed through
a Superdex 200 10/300 GL (Pharmacia) gel filtration column equilibrated
with buffer (10 mM Tris [pH 7.5], 150 mM NaCl, 10% glycerol, 5 mM
DTT). Protein concentrations were determined from the absorbance at
280 nm, and aliquots of the purified protein were stored in the same buffer
at80°C.
Nsp15 endoribonuclease assay. The substrate used in this assay is
four nucleotides in length and has a 5= fluorophore carboxyfluorescein
(FAM) and a 3= tetramethyl rhodamine that quenches FAM fluorescence
(Integrated DNA Technologies) when the substrate is intact. The cognate
nucleotide is a ribonucleotide, whereas the other three are deoxyribo-
nucleotides. The fluorescence released by incubation of purified Nsp15
protein with the substrate was measured in real time using an LS55 spec-
trometer (Perkin-Elmer, Inc.) as described earlier (4).
Coimmunoprecipitation assays. 293T cells were grown to 80%
confluence and, using Lipofectamine 2000 reagent (Invitrogen, Inc.), they
were transfected with plasmids to coexpress pRbABC (spanning ABC do-
mains of pRb) and either sNsp15 containing a C-terminal hemagglutinin
(HA) tag (sNsp15HA [kindly provided by Ralph Baric]) or LC mutant
tagged similarly at the C terminus (LCHA). At 48 h posttransfection, the
cells were lysed in cell lysis buffer (20 mM Tris [pH 7.5], 150 mM NaCl, 10
mM EDTA, 1% NP-40, 10% glycerol), and extracts were prepared as
described earlier (28). Extracts (500 g) clarified by centrifugation at
10,000  g for 30 min at 4°C were mixed with anti-pRb monoclonal
antibody 4H1 (Cell Signaling Technology; catalog no. 9309) at a 1:100
dilution. After a 4 h of incubation at 4°C, 20 l of a slurry of pre-equili-
brated Protein A/G Plus-agarose (Santa Cruz Biotechnology, Inc.; catalog
no. sc-2003) was added to the extracts, followed by incubation overnight
at 4°C with rocking. The resin was washed twice with cell lysis buffer and
collected by centrifugation. The resin was then resuspended in 1 elec-
trophoresis sample buffer to elute proteins for SDS-PAGE and Western
blot analysis. The Western blots were probed using anti-HA antibody
(Abcam, Inc.; catalog no. ab9134) or anti-ubiquitin monoclonal antibody
P4D1 (Santa Cruz Biotechnology, Inc.; catalog no. sc-8017).
Cell viability and fluorescence-activated cell sorting (FACS) analy-
sis. Nsp15-transfected Huh7 cells were harvested by trypsinization. They
were washed with PBS twice and then with 1 annexin V binding buffer
once. The cells were stained with annexin V-fluorescein isothiocyanate
(FITC) according to the provider’s recommendations (eBioscience, Inc.;
catalog no. 88-8005). Dead cells were stained with 7-AAD (BD Pharmin-
gen; catalog no. 51-68981E) for 5 min at room temperature. Data were
collected on a FACSCalibur (BD Biosciences, San Jose, CA) and analyzed
by using WinMDI software.
Fluorescence microscopy. Expression vector or sNsp15 (sNsp15HA,
LCHA, or H249AHA)-transfected Huh7 cells were seeded on eight-well
glass chamber slides. After being washed with PBS, cells were fixed with
4% paraformaldehyde at room temperature for 15 min. After three addi-
tional washes with PBS, the cells were permeabilized with ice-cold 100%
methanol at20°C for 10 min, rinsed with PBS for 5 min, and incubated
with blocking buffer (5% normal fetal bovine serum and 0.5% Triton
X-100 in PBS) for 1 h at room temperature. Anti-HA and anti-pRb (4H1)
antibodies were used to detect Nsp15 and pRb, respectively, at a 1:200
dilution using antibody dilution buffer (1% bovine serum albumin and
0.5% Triton X-100 in PBS). After three washes with PBS-T (0.5% Tween
20 in PBS), the slides were incubated with anti-goat IgG secondary anti-
body conjugated with Texas Red to detect Nsp15 or anti-rabbit immuno-
globulin secondary antibody conjugated with FITC to detect pRb for 1 h at
room temperature (at 1:200 dilution). The slides were washed with PBS-T
three times and mounted in Vectashield mounting medium (Vector Lab-
oratories). The images were obtained on Leica TCS SP5 scanning confocal
microscope with an HCX PL APO Lambda Blue 63X1.4 oil objective lens
(Leica Microsystems). Excitation was at 20% Hz, and the image resolu-
tion was 512 512 pixels. Images were analyzed using Leica Application
Suite 2.02.
Colony formation assay. NIH 3T3 cells were seeded in six-well plates
at 0.25 106 cells per well and transfected either with pUNO vector alone
or with sNsp15 expressed from pUNO vector using Lipofectamine 2000
reagent. At 24 h after transfection, each well of cells was transferred into a
10-cm culture dish and allowed to grow in medium containing 10 g of
blasticidin/ml. The cells were fed with fresh medium containing 10 g of
blasticidin/ml every 3 days. Four weeks later, the colonies were fixed in
methanol and stained with 1% crystal violet prepared in 20% ethanol.
Cell cycle analysis. NIH 3T3 cells were transfected in 10-cm culture
dishes either with vector alone or vectors expressing WT sNsp15 using
Lipofectamine 2000 reagent. The cells were harvested 36 h posttransfec-
tion, washed with PBS, and resuspended at 2  106 cells per ml of cold
PBS. The cell suspension was added dropwise to an equal volume of cold
absolute ethanol with continuous vortexing to fix the cells. After an over-
night incubation at 4°C, cellular DNA was stained with 500 g of pro-
pidium iodide (Invitrogen, Inc.)/ml prepared in PBS containing 0.1%
(vol/vol) Triton X-100 (Sigma-Aldrich) and 2 mg of DNase-free RNase A
(Sigma-Aldrich) at 37°C for 15 min in the dark. The samples were filtered
through nylon mesh to remove cell clumps and analyzed by using a
FACSCalibur flow cytometer (BD Biosciences, San Jose, CA). A total of
15,000 cells were analyzed using ModFitLT V3.0.
Luciferase reporter assay. NIH 3T3 cells were plated in Costar White
96-well plates at 4 104 cells per well for transfection. At approximately
60 to 80% confluence, they were cotransfected with 5 ng of the reporter
plasmid phRL-TK (Promega) or phRL-CMV (Promega), along with in-
dicated amounts of either the expression vector for H249A HA sNsp15 or
with the expression vector alone. The cells were incubated for 48 h to allow
expression from the plasmids. The Dual-Glo luciferase assay system (Pro-
mega), was used to quantify luminescence with the FLU-Ostar Optima
Plate Reader (BMG Labtech). The fold induction was calculated by nor-
malizing the data with vector control.
Mutant MHV construction. The MHV-A59 1000 reverse-genetics
system (43) was used to recover viruses with mutations in mNsp15.
Briefly, a 3.4-kb BamHI-HpaI fragment spanning the region of interest in
mNsp15 from the F plasmid (43) was amplified and cloned into the
pGEM-T vector as described previously (20). The LC mutation was intro-
duced into mNsp15 using a QuikChange II site-directed mutagenesis kit
(Stratagene) according to the manufacturer’s instructions. The sequence
of BamHI-HpaI fragment carrying the mutations in mNsp15 was deter-
mined to confirm that the desired sequences were obtained. The BamHI-
HpaI fragment containing the mutations was excised and religated into
plasmid F digested with the same enzymes. The ligation products were
then transformed into the Top10 strain of E. coli. The region of the recov-
ered clones between the BamHI and HpaI sites was sequenced again to
verify that the desired mutations were recovered. MHV-A59 genomes
containing mNsp15 WT and the mutant sequences were generated by
ligation of cDNAs followed by in vitro transcription and these genomes
were then electroporated into BHK-R cells as previously described (43).
Cultures were observed for 72 h posttransfection for the development of
cytopathic effects or syncytium formation. Virus-infected cultures were
then harvested and frozen at70°C. Mutant viruses were subjected to one
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round of plaque purification and amplified once in DBT cells to generate
stocks. The sequences of recovered viruses corresponding to the 5= and 3=
UTRs, as well as the portions encoding mNsp15 mutant proteins, were
amplified by reverse transcription-PCR, followed by direct sequencing of
the amplified products.
MHV growth and plaque formation assay. Growth curves for MHV
were determined in L2 cells seeded in 96-well plates and grown in 0.1%
serum supplemented growth medium for 48 h. The cells were infected at
a multiplicity of infection (MOI) of 1.0 with mNsp15 mutant (vLC) or
WT MHV-A59 for 1 h. The cells were washed to remove the unattached
virus that was remaining in the medium. Cultures were fed and further
incubated until 0, 10, 12, 16, 24, 28, and 30 h postinfection (hpi), at which
time they were frozen at70°C. Triplicate samples were obtained for all
time points. Virus production was quantified by plaque assays on mono-
layers of L2 cells.
pRb overexpression and analysis of theMHVnucleocapsid (N) pro-
tein. DBT cells (2.5  105 per well) were seeded onto 12-well plates and
transfected with either the expression vector (pUNO) or vector expressing
pRb ABC domains (pRbABC) using Lipofectamine 2000 reagent. At 6 h
after transfection, the cells were washed and fed with fresh medium. At
36 h after transfection, the cells were infected with either WT or vLC
MHV at an MOI of 5.0. At 4, 6, 8, 10, and 12 hpi, the medium was
removed, and the cells were lysed with 1 electrophoresis buffer. An
equal amount of lysate was electrophoresed on 4 to 12% NuPAGE Bis-
Tris gels (Invitrogen, Inc.) and transferred to polyvinylidene difluoride
membranes for Western blotting. Protein was detected with anti-MHV N
protein monoclonal antibodies and horseradish peroxidase-conjugated
anti-mouse secondary antibody (Santa Cruz Biotechnology) and the Am-
ersham ECL Plus Western detection system according to the manufactur-
er’s recommendations. After detection of the MHV N protein, the blots
were stripped with Tris (pH 7.0) containing 2% SDS and 50 mM DTT for
2 h at 37°C and probed for pRb using anti-pRb monoclonal antibody 4H1.
RESULTS
Coronavirus Nsp15 orthologs interact with pRb. A search for
motifs within the SARS-CoV Nsp15 (sNsp15) identified the
LXCXE/D motif that is characteristic for proteins that bind to the
retinoblastoma protein (pRb) (26). The motif lies within 10 Å of
the endoribonuclease active site of sNsp15 and is exposed on the
protein surface (Fig. 1A and B). The same motif was found in the
Nsp15 orthologs of alpha and beta coronaviruses, and a partial list
is shown in Fig. 1C. The LXCXE/D motif, however, was not pres-
ent in all of the Nsp15 orthologs of all coronaviruses. For example,
the Nsp15 orthologs of transmissible gastroenteritis virus (TGEV;
an alpha coronavirus), infectious bronchitis virus (IBV, a gamma
coronavirus), and turkey coronavirus (TCoV, a gamma coronavi-
rus) all lacked this motif. Toroviruses such as equine torovirus
(EToV) and arteriviruses such as LDC-V also lacked a recogniz-
able LXCXD motif in Nsp15. Interestingly, an LXCXD motif is
present in other 1ab proteins. For example, the motif is found in
FIG 1 pRb-binding motif in the SARS-CoV Nsp15 protein and in proteins of other coronaviruses. (A) Localization of the pRb-binding motif (purple) relative
to the endoribonuclease catalytic site (orange) on SARS-CoV Nsp15 (sNsp15) hexamer. The structure of SARS-CoV Nsp15 was from Bhardwaj et al. (3) (Protein
Data Bank: 2RHB). The Nsp15 protein was from the Urbani isolate (GenBank accession no. AY278741). (B) Close-up view showing orientation and distance
between the residues of pRb-binding motif (purple) and the endoribonuclease catalytic site (orange) on sNsp15. (C) Sequence alignment of the pRb-binding
motif in the Nsp15 orthologs. The following list gives the names of the viruses examined for the presence of the pRb-binding motif, followed by the GenBank
accession numbers in parentheses: SARS-CoV (NC_004718), MHV (NC_001846), BCoV (AF391542), HCoV OC43 (ay391777), PheV (YP_459949.1), EcoV
(YP_001671996), HCoV HKU1 (ay597011), BatCoV HKU5 (ef065509) HCoV 229E (NC_002645), PeDV (AEQ55003), HCoV NL63 (ABE97136), BatCoV
HKU8 (ACA52170), Scotophilus batCoV (YP_001351683), and Rhinolophus batCoV HKU2 (ABQ57231). The residue number of the first residue of the motif in
the proteolytically processed Nsp15 or Nsp15 ortholog is shown. Several nidoviruses lack the Rb-binding motif within the Nsp15 ortholog but contain such a
motif within other replication-associated proteins. Two examples of the motifs within the ORF1a of TGEV (NC_002306) and IBV (NC_001451) are shown.
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the 1a proteins of TGEV 1a and IBV (Fig. 1C). The functional
relevance of these motifs in other coronaviruses will not be ad-
dressed in this work.
We speculate that the pRb would bind sNsp15 and affect its
endoribonuclease activity. To test this, we produced a recombi-
nant truncated form of human pRb (pRbAB) that is sufficient to
bind to the LXCXE/D motif (23) (Fig. 2A). We also expressed and
purified the WT and a mutant sNsp15 named sLC that has alanine
substitutions of L331 and C333 of the LXCXD motif (mutated
residues underlined) (Fig. 2A). Size-exclusion chromatography
revealed that both WT sNsp15 and the sLC mutant eluted pre-
dominantly as hexamers, a feature necessary for Nsp15 endoribo-
nuclease activity (16; data not shown). Furthermore, the sLC mu-
tant preferentially cleaved a tetranucleotide fluorophore substrate
containing a cognate uridylate, and its activity was dependent on
Mn2 similar to the WT sNsp15, demonstrating that the mutation
did not affect endoribonuclease activity (data not shown). In the
presence of increasing concentrations of pRbAB, the rates of sub-
strate cleavage by WT sNsp15 increased proportionally, while
cleavage by the sLC mutant was not particularly affected (n  3,
P 0.0001; Fig. 2B). The WT MHV Nsp15 (mNsp15) also exhib-
ited increased endoribonuclease activity in the presence of pRb
(Fig. 2B). These results show that sNsp15 endoribonuclease activ-
ity does not require pRb, but that there may be interactions be-
tween the proteins.
To determine whether sNsp15 can interact with pRb in cells,
we ectopically coexpressed human pRb spanning the ABC do-
mains (pRbABC), along with either an HA-tagged sNsp15
(sNsp15HA) or the mutant with alanine substitutions of L331 and
C333 in the LXCXD (mutated residues underlined) motif (LCHA)
in 293T cells. The cell lysates were immunoprecipitated with
monoclonal antibody to pRb and then subjected to Western blot
to detect the HA tag in Nsp15. Notably, LCHA expression in cells
was found to be lower than that of sNsp15HA (see below for addi-
tional examination of the LCHA protein). Therefore, we used four
times the amount of LCHA-expressing lysate to adjust for compa-
rable amounts of WT and LC sNsp15 for immunoprecipitation.
The volume for WT sNsp15HA was adjusted similarly with vector-
transfected cell lysate. WT sNsp15HA was found to coimmunopre-
cipitate with pRb but not the LCHA mutant (Fig. 2C). In an inde-
pendent assay, purified recombinant GST-tagged pRb (pRb-GST)
was bound to glutathione-Sepharose resin and incubated with cell
lysates expressing either sNsp15HA or LCHA. After extensive
washes, the bound materials were eluted and subjected to Western
blot analysis. WT sNsp15HA but not the LCHA mutant was readily
detected in the bound material (Fig. 2D). These results show that
Nsp15 binds to pRb in cells and that the LXCXD/E motif contrib-
utes to the binding. This encouraged us to determine the conse-
quences of pRb-Nsp15 interaction.
LCHA mutant accumulates to lower levels, is differentially
modified, and exhibits increased apoptosis and cell death. We
consistently observed that the extracts from transiently trans-
fected cells contained lower amounts of LCHA protein than did the
sNsp15HA (Fig. 3A). Furthermore, on denaturing polyacrylamide
gels, the LCHA protein migrated as multiple bands, both larger and
smaller than the molecular mass of the Nsp15 monomer that are
FIG 2 Interaction between pRb and Nsp15. (A) SDS-PAGE analysis of the purified proteins— human pRbAB (pRb-spanning AB domains), sLC (pRb-binding
mutant of SARS-CoV Nsp15), and sNsp15 (SARS CoV Nsp15)— used in the study. (B) Effect of pRbAB addition on the endoribonuclease activity of (sNsp15),
sLC, and MHV Nsp15 (mNsp15). (C) Coimmunoprecipitation of sNsp15HA (HA-tagged sNsp15) with coexpressed pRbABC (pRb-spanning ABC domains) from
cellular lysates. The LCHA (HA-tagged pRb-binding mutant of sNsp15) and vector are shown as specificity controls. Antibodies used for immunoprecipitation
(IP) and immunoblotting (IB) are shown on the left. The expected position of Nsp15 migration on gel (40 kDa) is shown on the right. (D) Western blot analysis
of various fractions collected upon passing sNsp15HA- or LCHA-expressing cellular lysates through a GST-pRbAB-bound glutathione-agarose column. Anti-HA
antibodies were used for the detection of Nsp15 (molecular mass,40 kDa).
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indicative of covalent modifications as well as degradation (Fig.
2C and 3A). This is in contrast to the sNsp15HA, which migrated at
the expected monomer molecular mass (40 kDa) (Fig. 2C and
3A). To test whether LCHA was modified by ubiquitin relative to
sNsp15, we coexpressed ubiquitin in the same cells. The cell lysates
were immunoprecipitated with anti-HA antibodies, followed by
Western blot analysis to detect ubiquitin. Both WT sNsp15HA and
LCHA were positive for ubiquitin (Fig. 3B). However, whereas
sNsp15HA migrated in one band indicative of a monoubiquiti-
nated form, LCHA existed in a ladder of bands that is expected for
a polyubiquitinated protein (Fig. 3B).
We also investigated whether cytotoxicity was a reason for
lower accumulation of LCHA. Huh7 cells were transfected with
sNsp15HA, LCHA, or the endoribonuclease mutant, H249AHA. At
36 h posttransfection, the cells were stained with annexin V-FITC
and 7-AAD to determine apoptosis and cell death, respectively.
FACS analysis showed that the cells transfected to express LCHA
had higher levels of apoptosis and cell death compared to
sNsp15HA- or H249AHA-transfected cells (n 3; P 0.0001; Fig.
3C). These results show that when Nsp15 cannot efficiently inter-
act with pRb, it is differentially modified and has cytotoxicity (Fig.
3B and C).
Ectopic expression of Nsp15 alters the cellular distribution
of pRb. Coronaviruses replicate in association with cytoplasmic
membranes, although some of their proteins can localize to the
nucleus (15). We wanted to determine the cellular localization of
Nsp15 and pRb. Huh-7 cells were transfected to express
sNsp15HA, LCHA, or H249AHA. Confocal immunofluorescence
microscopy images showed that sNsp15HA localizes predomi-
nantly in the cell cytoplasm (Fig. 4A). Notably, not all of the cells
within an image were successfully transfected. pRb was localized
predominantly in the nuclei of cells that were not expressing
sNsp15HA. However, in cells expressing sNsp15HA or H249AHA,
pRb was detected both in the cytoplasm and the nucleus (Fig. 4A
and B).
To determine whether pRb redistribution requires interaction
with Nsp15 via the LXCXE/D motif, we analyzed pRb localization
in LCHA-transfected cells. Consistent with the results from West-
ern blots, LCHA was less abundant, and hence the gain was ad-
justed higher than that for WT sNsp15HA or H249AHA. We also
identified cells with higher levels of LCHA proteins. Even with
these manipulations, preferential redistribution of pRb into the
cytoplasm in cells was not detected in cells expressing LCHA (Fig.
4C). Furthermore, we note that LCHA was present at similar levels
in both the nucleus and the cytoplasm in a majority of the trans-
fected cells.
To confirm the relocalization of pRb by WT sNsp15, we sepa-
rated the nuclear and cytoplasmic fractions of cells transfected to
express sNsp15 and performed Western blots to detect pRb. An
increase in the abundance of pRb was observed in the cytoplasmic
fraction in three independent experiments, and representative re-
sults are in shown in Fig. 4D. These results show that expression of
sNsp15 is correlated with a redistribution of pRb in cells.
Nsp15 affects pRb function. Oncoproteins from DNA tumor
viruses can bind pRb and induce NIH 3T3 cells to undergo contact-
independent cell growth in a focus formation assay (9, 11, 21, 23, 29,
41). We sought to determine whether sNsp15 had the ability to in-
crease focus formation. NIH 3T3 fibroblasts were transfected to ex-
press sNsp15 or empty expression vector. After 4 to 5 weeks of selec-
tion, the cells were stained with crystal violet. In four independent
experiments, plates containing the cells transfected to express sNsp15
had severalfold higher cell number compared to the cells transfected
with the empty vector (Fig. 5A). Cells expressing sLC did not increase
colony formation but, due to the pleiotropic effects associated with
sLC, it is difficult to interpret these results.
The lack of contact-inhibition in cell growth suggests that
sNsp15 interacted with pRb perturbed the regulation of the cell
cycle. To examine this directly, NIH 3T3 cells were transfected to
express the vector or sNsp15. The amount of DNA in 15,000 cells
per sample was quantified using FACS to determine the number of
cells in different phases of cell cycle. In three independent exper-
iments, cells expressing sNsp15 consistently had ca. 2 to 3% more
cells in S phase compared to those transfected with the empty
vector (n  3, P  0.0001; Fig. 5B). We note that the effects
observed are likely to be underestimated due to the efficiency of
transfection being100%.
Finally, we examined whether sNsp15 could alter expression of
Renilla luciferase driven from the thymidine kinase (TK) pro-
moter, which is normally repressed by pRb (8). In this assay, an
interaction between sNsp15 and pRb should increase TK pro-
moter activity. An active-site mutant of sNsp15, H249A, was used
in this experiment since expression of WT sNsp15 potentially
could nonspecifically reduce reporter expression due to the en-
doribonuclease activity. The H249A mutant of sNsp15 increased
Renilla luciferase levels in a concentration-dependent manner
FIG 3 Properties of pRb-binding mutant Nsp15. (A) Western blot analysis of
lysates from vector-, sNsp15HA-, or LCHA-transfected 293T cells. Blots were
probed with anti-HA antibodies. The expected position of Nsp15 migration on
the gel (40 kDa) is shown. (B) Western blot showing coimmunoprecipita-
tion of ubiquitin with sNsp15HA and LCHA from cell extracts. Vector-trans-
fected cells were used as a control. Anti-HA antibodies were used for immu-
noprecipitation, and anti-ubiquitin antibodies were used for Western blotting.
(C) FACS analysis. A summary of the cells (%) undergoing apoptosis and cell
death upon expression of sNsp15HA, LCHA, or H249AHA (endoribonuclease
mutant of SARS Co-V sNsp15) is presented in the table. The cells were trans-
fected to express sNsp15HA, LCHA, or H249AHA (the endoribonuclease mutant
of sNsp15) and stained to detect annexin V and DNA with propidium iodide
(PI). For data analysis, the cells were divided into four quadrants based on the
intensity of the signal from annexin V and PI. The table shows the mean
percentages of the cells in each quadrant, and the values were interpreted as
follows. The live cells are negative for both annexin V PI (live), the apop-
totic cells are positive for positive for annexin A but negative for PI, the dead
cells are negative for annexin V but positive for PI, and the cells that are both
apoptotic and dead are positive for both signals.
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(Fig. 5C). The same effects were not observed with luciferase ex-
pressed from a human cytomegalovirus (CMV) promoter that is
not regulated by pRb. Altogether, the results from the NIH 3T3
focus formation, the proportions of cells in the S phase of the cell
cycle, and the results from pRb-responsive promoter-reporter as-
say support the idea that the SARS-CoV Nsp15 can alter pRb
regulation of cell growth and gene expression.
Nsp15 downregulates pRb accumulation. Several viral pro-
teins that interact with pRb can accelerate its degradation (5, 21,
27). To determine whether this also takes place with sNsp15, the
level of pRBABC was examined in transiently transfected 293T cells
by Western blotting. In six independent assays, cells expressing
WT sNsp15 had 3- to 4-fold lower amount of pRb compared to
the vector control (Fig. 6A). The endoribonuclease-deficient mu-
tant H249A also reduced pRb levels, although not to the same
extent as the WT sNsp15 (Fig. 6A), indicating that reduction in
pRb level by Nsp15 could be a combined effect of its endoribonu-
clease activity and enhanced protein degradation.
FIG 4 Distribution of pRb in cells expressing different forms of sNsp15. (A to C) Distribution of pRb (green) in Huh-7 cells transfected to express sNsp15HA
(red) (A), H249AHA (B), and LCHA (C). Due to the efficiency of transfection, each microscopic image contains both cells expressing sNsp15 and those that do not.
To facilitate comparison of the images, a representative cell positive for WT or mutant sNsp15 is identified by a “” symbol in all three sets of images. A typical
cell that did not express WT or mutant sNsp15 is identified by the symbol “”. In the presence of sNsp15, pRb is more diffused and colocalized to the cytoplasm
with sNsp15. The three panels to the right show a merged image of pRb and Nsp15 staining. In panel C, a montage was prepared to increase the sample size due
to the lower expression and/or transfection efficiency of LCHA. The white scale bar in the lower right corner indicates 25 mm. (D) Western blot showing pRb levels
(upper panel) in the nuclear (N) and cytoplasmic (C) fractions of transfected Huh7 cells. The middle panel shows the expression of Nsp15, as judged by probing
the blot with anti-HA antibodies. GAPDH (glyceraldehyde-3-phosphate dehydrogenase) is shown as a loading control (lower panel).
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pRb abundance has been shown to be regulated by several
pathways, including ubiquitin-dependent proteolysis by the pro-
teasome (39). To determine whether the reduction in pRb levels
was due to enhanced proteolysis in the presence of sNsp15, we
treated sNsp15HA-transfected cells with the proteasome inhibitor
MG132 and observed that pRb levels increased by up to 4-fold
without affecting sNsp15 levels (Fig. 6B). This result suggests that
the effect of sNsp15 on pRb accumulation involves the protea-
some.
Next, we examined whether decreased pRb levels is correlated
with increased ubiquitination. An antibody specific to pRb was
used to immunoprecipitate the cell lysates and the precipitated
material subjected to Western blotting with a monoclonal anti-
body to ubiquitin (Fig. 6C). In addition to the IgG used in the
immunoprecipitation assay, a smear with extra density was found
to emanate from a band of the mass corresponding to unmodified
pRb, a finding consistent with the increased ubiquitination of pRb
in the presence of sNsp15.
Interaction between pRb and Nsp15 is required for optimal
MHV infection. To examine whether the interaction between
Nsp15 and pRb is significant for virus infection in cell culture, we
used MHV (strain A59) as a surrogate coronavirus. MHV is a
suitable substitute for SARS-CoV since its Nsp15 protein
(mNsp15) has a structure nearly identical to that of the SARS-CoV
Nsp15 and an identical mechanism of cleavage (42). Furthermore,
it has a pRb-binding sequence, and the endoribonuclease activity
of the recombinant mNsp15 was also increased in the presence of
pRb (Fig. 1A and 2B).
To disrupt the interaction between Nsp15 and pRb, we con-
structed a mutant MHV named vLC where two residues of the
putative pRb-binding sequence (LWCNE) were mutated to ala-
nines (AWANE; mutated residues underlined) using the reverse
genetic system described by Yount et al. (43). Mutant vLC formed
plaques on L2 cell line monolayers that were consistently reduced
in their diameters to ca. 60% of those formed by WT MHV (Fig.
7A and B). The peak virus titer obtained by vLC was reduced
between 5-fold and 1 log compared to the WT MHV in three
experiments (Fig. 7C). These results suggest that the loss of inter-
action between pRb and mNsp15 is detrimental to optimal MHV
infection.
pRb is redistributed and downregulated duringMHV infec-
tion. We wanted to examine whether MHV infection would affect
the accumulation and cellular distribution of pRb. L2 cells were
infected either with WT or with vLC MHV at an MOI of1.0 for
4 h and examined by immunofluorescence microscopy. The cells
were stained to detect pRb, as well as the MHV N protein. pRb was
localized primarily in the nucleus of uninfected cells (Fig. 8A,
upper panels). However, in the WT MHV-infected cells, a signif-
icant amount of pRb was also present in the cytoplasm (Fig. 8A,
middle panels). A similar cytoplasmic distribution of pRb was not
observed in cells that were infected with vLC (Fig. 8A, lower pan-
els). In addition, most of the vLC-infected cells appeared to be
larger in size than WT MHV-infected cells, and N protein was
present both in the nucleus and in the cytoplasm, unlike WT
FIG 5 Effect of SARS Co-V Nsp15 on pRb-regulated processes. (A) Colony
formation assay. The images show the growth of sNsp15- or vector-transfected
NIH 3T3 cells. Colonies were stained with crystal violet. (B) Cell distribution
in various phases of the cell cycle in vector or sNsp15-transfected cells as
analyzed by FACS. (C) Effects of expressing H249A (endoribonuclease mutant
of sNsp15) on luciferase expression from the thymidine kinase (TK) promoter
() and the CMV promoter (Œ).
FIG6 Cellular levels of pRb. (A) Western blot showing the expression levels of
pRbABC in cells coexpressing either vector, sNsp15HA, or H249AHA. (B) Effect
of proteasome inhibitor MG132 on the levels of pRbABC in the presence of
sNsp15HA. (C) Western blot showing the amount of ubiquitinated pRb in
either vector (V)- or sNsp15HA-transfected cells. Anti-pRb monoclonal anti-
bodies were used for immunoprecipitation (IP), and anti-ubiquitin antibodies
were used for Western blotting (IB) The expected position of pRbABC is indi-
cated with a star. The blot was stripped and reprobed with anti-pRb antibodies
(bottom panel).
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MHV-infected cells, where it was primarily cytoplasmic, a finding
consistent with our previous observation that the LC mutant of
the sNsp15 had pleiotropic effects on the physiology of the cells.
To examine pRb accumulation during MHV infection, L2 cells
were infected with WT or vLC MHV or mock infected. The
amounts of pRb in whole-cell lysates and cytoplasmic fractions
were determined by Western blotting. Analysis of the whole-cell
lysates shows that the amount of pRb was slightly lower in WT
MHV- and vLC-infected cells compared to uninfected cells (Fig.
8B), whereas there was an2-fold-higher level of pRb in the cy-
toplasmic fractions of WT MHV-infected cells compared to un-
infected or vLC-infected cells 1 hpi (Fig. 8C). These data demon-
strate that MHV infection could increase pRb accumulation in the
cytoplasm (Fig. 8). In addition, redistribution of pRb was ob-
served as early as 1 h after MHV infection. There was an2-fold
reduction in pRb accumulation and appearance of degradation
product by WT MHV at 5 hpi. In contrast, the cytoplasmic pRb
levels in cells infected with vLC remained apparently unaltered
even by 5 hpi (Fig. 8C). The decrease in pRb levels by WT MHV
infection by Western blot analysis was greater than that observed
in the microscopy images, where pRb appears to be much brighter
in the WT MHV infection (Fig. 8A). A potential explanation for
this could be the detection of both partially degraded and full-
length pRb in the microscopy experiments, while the Western blot
results were for the full-length pRb. These results show that MHV
infection is accompanied by pRb redistribution and downregula-
tion, likely due to its interaction with Nsp15.
Effect of cellular levels of pRb onMHV infection. We reason
that if pRb is downregulated during MHV infection, overexpres-
sion of pRb should negatively affect the MHV infection. Further-
more, overexpressing pRb should have less of an effect on the vLC
mutant. To examine this possibility, we ectopically expressed
pRbABC in DBT cells prior to infection by either WT or vLC MHV.
Vector-transfected cells were used as a control. At the indicated
times after infection, the cells were harvested to analyze the level of
the MHV N protein by Western blotting. Cells with overexpressed
pRbABC exhibited a delayed appearance of N protein by up to 2 h
compared to the cells transfected with the empty vector (Fig. 9).
Furthermore, pRb overexpression apparently did not affect N
protein appearance in cells infected with vLC. Identical results
were observed in two independent experiments. We note that the
pRbABC levels were decreased by both WT and vLC MHV after 8
hpi (Fig. 9, bottom panels).
DISCUSSION
In this study, we found that Nsp15 can interact with pRb, increase
expression of genes that are normally repressed by pRb, and in-
crease the proportion of cells in the S phase of the cell cycle. The
virus titer produced by an MHV with a mutation in Nsp15 that
affected interaction with pRb was reduced by up to 1 log. Further-
more, overexpression of pRb in cells delayed the timing for N
protein expression. These results support the idea that the coro-
naviruses can affect cell cycle-associated gene expression through
a novel function of the putative endoribonuclease, Nsp15, likely to
alter the metabolic status of the host cells to their advantage.
The effect of host metabolic status on virus replication was
highlighted by the observation that transformed cells are better
hosts for murine hepatitis coronavirus (40). Further, the impor-
tance of a coronavirus affecting cellular gene regulation through
cell cycle progress is underscored by the Nsp1 protein of MHV,
which has been reported to inhibit progression into the cell cycle
at the G0/G1 transition by decreasing Cdk1 levels and accumulat-
ing hypophosphorylated pRb (6). Since the LXCXD/E motif binds
preferentially to hypophosphorylated pRb (23), it is conceivable
that Nsp1 accumulates the hypophosphorylated form of pRb for
interaction with Nsp15.
Our observations of increased relocalization of pRb to the cy-
toplasm and association with ubiquitin indicate that a conse-
quence of the interaction with Nsp15 is the degradation of pRb,
likely by the ubiquitin/proteasome pathway. The proteins tumor
suppressor p53 and p27Kip1 are also redistributed to the cytoplasm
for their degradation (14, 19). We note with interest that Nsp15
lacking the WT pRb-binding site (sLC) accumulates to lower lev-
els and has significant cytotoxicity, suggesting that interaction
with pRb stabilizes Nsp15 and has other consequences for viral
infection. It is not yet clear why Nsp15 appears to require pRb for
its own stability and enhances the downregulation of pRb. How-
ever, the observed effects on pRb-regulated processes and gene
expression are likely due to a direct protein interaction since pRb
can coimmunoprecipitate with Nsp15 and increase the endoribo-
nuclease activity. Furthermore, we note with interest that Nsp15
lacking the wild-type pRb-binding site had significant cytotoxic-
ity, suggesting that interaction with pRb has other consequences
for viral infection.
Especially important to MHV infection is that an effect on pRb
was observed by 1 h after infection, suggesting that debilitating
pRb is an early event in infection (Fig. 8 and 9). We also observed
a dramatic reduction in pRbABC levels after 8 hpi (Fig. 9) during
the infection by both WT and vLC MHV. This effect is probably
due to the host translational shutoff induced by MHV. Although a
mutation to prevent Nsp15 and pRb interaction only reduced
MHV virion production by up to 1 log in a single round of infec-
FIG 7 Plaque morphology and growth curve of vLC mutant MHV. (A) Rep-
resentative plaque morphology of WT and vLC mutant MHV A59. (B) Diam-
eter of plaques generated by four independent vLC mutant versus the WT
MHV A59. (C) PFU generated by WT or vLC MHV as a function of time.
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tion, it is likely to have a much more dramatic effect in a host
organism during multiple rounds of infection. Further, pRb inter-
acts with several cellular proteins and regulates the expression of
multiple genes, including those associated with the cell cycle (32),
and immune response genes, including those associated with in-
terleukin-6 (IL-6) and IL-8 (7, 44). DNA tumor viruses and HCV
are linked to cancer, and interaction with pRb provides one mech-
anism to alter regulation of cell cycle progression. Coronaviruses
FIG 8 Distribution and levels of pRb during MHV infection. (A) Confocal microscopy images of L2 cells showing the distribution of pRb (red) and MHV N
protein (green) in untreated cells (top panels), WT MHV-infected cells (middle panels), and vLC MHV-infected cells (lower panels). Right panels show a merged
image of pRb and N protein staining. pRb is stained with rabbit anti-mouse antibody and Texas Red conjugated anti-rabbit secondary antibody. N protein is
stained with anti-MHV N protein monoclonal antibodies and Alexa Fluor 488-conjugated anti-mouse secondary antibody. The white scale bar in the right panels
indicates 25m. (B) Western blots showing the levels of pRb in whole cells lysates (top panel). The level of GAPDH was used as a loading control (bottom panel).
(C) Western blots showing the levels of pRb in the cytoplasmic fraction (top and middle panels). GAPDH (bottom panel) serves as a loading control. L2 cells were
infected either with WT or vLC MHV. Cells were harvested 1 or 5 hpi. Uninfected cells (UI) were used as a control. Western blots are probed with anti-pRb
antibodies in panels B and C.
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are not known to be associated with cancer, but perturbing cell
cycle regulation will affect the metabolism of the cell and the ac-
cumulation of gene products to favor optimal viral infection.
We observed that many, but not all members of the alpha and
beta coronaviruses contain a Rb-binding motif on their endoribo-
nuclease (Fig. 1A). Interestingly, members of gamma coronavirus
genus and related nidoviruses lack an LXCXE/D sequence on their
orthologs of Nsp15. However, such motifs can be found in other
protein in open reading frame 1ab. This suggests that interaction
with Rb may be important, although endoribonuclease activity
does not require this interaction. The functional relevance of the
observed motifs in other nidoviruses needs to be investigated di-
rectly prior to making any conclusions about the specific require-
ments of Rb interaction in the infection process.
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